TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
New tuberculosis data have been reported by scientists at University of Cape Town
September 2nd, 2008
According to recent research published in the Jama - Journal of the American Medical Association, "Context Rifampicin- based antitubercular therapy reduces the plasma concentrations of nevirapine and efavirenz. The virological consequences of these interactions are not well described." " To assess the effectiveness and tolerability of concomitant efavirenz- or nevirapine-based combination antiretroviral therapy and rifampicin- based antitubercular therapy. Setting, and Participants Cohort analysis of prospectively collected routine clinical data in a community - based South African antiretroviral treatment program. Antiretroviral treatment- naive adults enrolled...
Source: TB & Outbreaks Week (2008-09-02)
|
